Aurora Financial Journal

Mercator Medical Spółka Akcyjna (MRC.WA)

Warsaw Stock Exchange · Financial statements, TTM figures and earnings dates

In fiscal year 2023 (ended December 31, 2023), Mercator Medical Spółka Akcyjna reported revenue of PLN 469.1M and net income of −PLN 19.7M. Annual financial statements are available for fiscal years 2020 to 2023, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

PLNFY2023
2023-12-31
FY2022
2022-12-31
FY2021
2021-12-31
FY2020
2020-12-31
Income statement
RevenuePLN 469.1MPLN 542.5MPLN 1.73BPLN 1.83B
Operating income−PLN 87.1M−PLN 181.2MPLN 463.4MPLN 1.05B
Net income−PLN 19.7M−PLN 189.6MPLN 446.9MPLN 930.2M
Diluted EPS−PLN 2.38−PLN 19.53PLN 43.95PLN 88.84
Cash flow
Operating cash flow−PLN 86.0KPLN 40.8MPLN 503.0MPLN 712.5M
Capital expenditurePLN 39.1MPLN 109.7MPLN 176.8MPLN 15.5M
Free cash flow−PLN 39.2M−PLN 68.9MPLN 326.2MPLN 697.0M
Balance sheet
Cash and equivalentsPLN 217.3MPLN 223.3MPLN 339.6MPLN 399.8M
Total assetsPLN 965.2MPLN 1.08BPLN 1.29BPLN 1.29B
Total liabilitiesPLN 105.5MPLN 73.8MPLN 143.3MPLN 246.2M
Total debtPLN 148.0KPLN 211.0KPLN 0PLN 686.0K
Shareholders' equityPLN 862.1MPLN 1.01BPLN 1.14BPLN 1.04B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in PLN as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full MRC.WA page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open MRC.WA financials →